These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2386959)

  • 1. Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown.
    Mahadevan V; Malik ST; Meager A; Fiers W; Lewis GP; Hart IR
    Cancer Res; 1990 Sep; 50(17):5537-42. PubMed ID: 2386959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between in vivo induction of cytokine gene expression by flavone acetic acid and strict dose dependency and therapeutic efficacy against murine renal cancer.
    Mace KF; Hornung RL; Wiltrout RH; Young HA
    Cancer Res; 1990 Mar; 50(6):1742-7. PubMed ID: 1689611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic alkalinization inhibits the ability of flavone acetic acid to augment natural killer activity, induce cytokine gene expression, and synergize with interleukin 2 for the treatment of murine renal cancer.
    Futami H; Hornung RL; Back TT; Bull R; Gruys E; Wiltrout RH
    Cancer Res; 1990 Dec; 50(24):7926-31. PubMed ID: 2253233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.
    Hornung RL; Back TC; Zaharko DS; Urba WJ; Longo DL; Wiltrout RH
    J Immunol; 1988 Nov; 141(10):3671-9. PubMed ID: 2460546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-dependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice.
    Thomsen LL; Ching LM; Zhuang L; Gavin JB; Baguley BC
    Cancer Res; 1991 Jan; 51(1):77-81. PubMed ID: 1988109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects.
    Baguley BC; Zhuang L; Kestell P
    Oncol Res; 1997; 9(2):55-60. PubMed ID: 9167186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavone acetic acid increases the antitumor effect of hyperthermia in mice.
    Sakaguchi Y; Maehara Y; Baba H; Kusumoto T; Sugimachi K; Newman RA
    Cancer Res; 1992 Jun; 52(12):3306-9. PubMed ID: 1596889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents.
    Zwi LJ; Baguley BC; Gavin JB; Wilson WR
    Oncol Res; 1994; 6(2):79-85. PubMed ID: 7949468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid.
    Browne WL; Wilson WR; Baguley BC; Ching LM
    Anticancer Res; 1998; 18(6A):4409-13. PubMed ID: 9891501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy.
    Evelhoch JL; Bissery MC; Chabot GG; Simpson NE; McCoy CL; Heilbrun LK; Corbett TH
    Cancer Res; 1988 Sep; 48(17):4749-55. PubMed ID: 3409216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma.
    Sun JR; Brown JM
    Cancer Res; 1989 Oct; 49(20):5664-70. PubMed ID: 2790784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of immune effector cells in flavone acetic acid-induced injury to tumor cells in EMT6 spheroids.
    Zwi LJ; Baguley BC; Gavin JB; Holdaway KM; Wilson WR
    Oncol Res; 1992; 4(8-9):333-9. PubMed ID: 1486217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of antitumor effects of flavone acetic acid by cortisone.
    Ching LM; Joseph WR; Baguley BC
    Anticancer Res; 1993; 13(4):1139-41. PubMed ID: 8352536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of experimental rat tumours and a mouse colon tumour to flavone acetic acid.
    Kal HB; de Graaff E; Van Berkel AH; Goedoen HH
    In Vivo; 1992; 6(1):73-5. PubMed ID: 1385730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice.
    Ching LM; Goldsmith D; Joseph WR; Körner H; Sedgwick JD; Baguley BC
    Cancer Res; 1999 Jul; 59(14):3304-7. PubMed ID: 10416582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).
    Ching LM; Joseph WR; Crosier KE; Baguley BC
    Cancer Res; 1994 Feb; 54(4):870-2. PubMed ID: 8313372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice.
    Plowman J; Narayanan VL; Dykes D; Szarvasi E; Briet P; Yoder OC; Paull KD
    Cancer Treat Rep; 1986 May; 70(5):631-5. PubMed ID: 3708611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent effects of flavone acetic acid on established versus developing tumour blood flow.
    Mahadevan V; Hart IR
    Br J Cancer; 1991 Jun; 63(6):889-92. PubMed ID: 1712621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-molecule cytokine inducers causing tumor necrosis.
    Baguley BC
    Curr Opin Investig Drugs; 2001 Jul; 2(7):967-75. PubMed ID: 11757800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.